Sarasota — Sarasota, Florida

Sarasota is a clinical research site located in Sarasota, Florida, United States.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarasota has participated in 9 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Colorectal Cancer, Heavy Menstrual Bleeding, Uterine Fibroid.

Sponsors: OncoMed Pharmaceuticals, Inc., Myovant Sciences GmbH, Sumitomo Pharma Switzerland GmbH.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarasota?

Sarasota has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarasota conducted?

Sarasota has 9 clinical trials on record, with 2 currently active. Their work covers Metastatic Colorectal Cancer, Heavy Menstrual Bleeding, Uterine Fibroid.

Is Sarasota accredited by Crixeo Health?

Yes — Sarasota holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarasota?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.